CLINICAL TRIAL article
Front. Sports Act. Living
Sec. Sport and Exercise Nutrition
Volume 7 - 2025 | doi: 10.3389/fspor.2025.1594733
This article is part of the Research TopicSports, Nutrition and Public Health: Analyzing their Interconnected ImpactsView all 14 articles
Adjuvant melatonin therapy during exercise prescription in breast cancer survivors on physical and anthropometric parameters, quality of life, and hormonal response. A randomized controlled trial
Provisionally accepted- 1University of León, León, Spain
- 2University Hospital of Salamanca, Salamanca, Spain
- 3University of Valladolid, Valladolid, Spain
- 4Emergency Department, Línea de la Concepción Hospital, Línea de la Concepción, Spain
- 5Miguel Hernández University of Elche, Elche, Valencian Community, Spain
- 6University of Salamanca, Salamanca, Spain
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Breast cancer has a high prevalence in women during the last years of their life. Exercise is instrumental during this recovery period. Nevertheless, little is known about the effects of combining nutritional supplements with physical activity. Therefore, this study aims to examine the impact of melatonin in conjunction with physical activity in breast cancer survivors (BCS). Methods: Participants were postmenopausal women (60-75 years old) who had been diagnosed with stage I-III breast cancer 5 years ago and had received chemotherapy or radiotherapy. Participants were randomly assigned to two groups: experimental group (MEL) (n=10), which received melatonin supplementation (6 mg/day), and the control group (CG) (n=10), which received a placebo. Both groups followed an adapted physical activity program. After 10 weeks, body composition, physical condition, health-related quality of life and hormonal pattern were assessed in a randomized, single-blind, placebo-controlled trial (Clinical Trials.gov ID NCT06696378) following the Consolidated Standards of Reporting Trials. A Twoway repeated-measures analysis of variance (ANOVA) was used to examine the interaction effects (time x group) between MEL and CG. A significance level of p < 0.05 indicated a statistically significant difference. Results: After 10 weeks, both groups showed a non-significant decrease (p > 0.05) in fat mass. Both MEL and CG exhibited a significant reduction (p < 0.05) in the Borg Rating of Perceived Exertion (RPE) when comparing the beginning (T1) and end (T2) of the study Additionally, statistically significant differences (p = 0.018) were observed overtime between T1 and T2 in the MEL and CG in RPE, with a moderate effect size (η²p = 0.347). On the other hand, the Quality-of-Life Questionnaire (four domains and total score) and Short Physical Performance Battery indicated no significant (p > 0.05) differences between MEL and CG. Finally, testosterone/cortisol ratio decreased in both groups at the end of intervention, but the difference was not statistically significant (p > 0.05). Conclusions: Melatonin supplementation (6 mg/day) for 10 weeks, combined with a physical activity program, had not significant (p > 0.05) effects on anthropometry, physical condition, health-related quality of life and hormonal response compared to the placebo group.
Keywords: Body Composition, breast cancer, cancer survivors, Exercise, Hormonal response, Melatonin, physical performance, quality-of-life
Received: 16 Mar 2025; Accepted: 02 Jun 2025.
Copyright: © 2025 Celorrio San Miguel, Cacharro, Santamaría, Garrosa, Celorrio, Roche, Garrosa and Fernández Lázaro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Enrique Roche, Miguel Hernández University of Elche, Elche, 03202, Valencian Community, Spain
Diego Fernández Lázaro, University of Valladolid, Valladolid, Spain
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.